|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/555 | (2006.01) |
| A61K 31/506 | (2006.01) | ||
| A61K 31/519 | (2006.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 39/395 | (2006.01) | ||
| C07K 16/28 | (2006.01) |
| (11) | Number of the document | 3883579 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19886683.2 |
| Date of filing the European patent application | 2019-11-18 | |
| (97) | Date of publication of the European application | 2021-09-29 |
| (45) | Date of publication and mention of the grant of the patent | 2025-12-24 |
| (46) | Date of publication of the claims translation | 2026-03-10 |
| (86) | Number | PCT/US2019/062064 |
| Date | 2019-11-18 |
| (87) | Number | WO 2020/106647 |
| Date | 2020-05-28 |
| (30) | Number | Date | Country code |
| 201862769355 P | 2018-11-19 | US | |
| 201962821376 P | 2019-03-20 | US | |
| 201962865819 P | 2019-06-24 | US |
| (72) |
LIPFORD, James Russell , US
CANON, Jude Robert , US
SAIKI, Anne Y. , US
REX, Karen Louise , US
|
| (73) |
Amgen Inc. ,
One Amgen Center Drive, Thousand Oaks CA 91320,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Kombinuota terapija, apimanti KRAS-G12C inhibitorių ir vieną ar daugiau papildomų farmaciškai aktyvių medžiagų, skirtų vėžio gydymui |
| COMBINATION THERAPY INCLUDING A KRAS-G12C INHIBITOR AND ONE OR MORE ADDITIONAL PHARMACEUTICALLY ACTIVE AGENTS FOR THE TREATMENT OF CANCERS |